The notices it replaced
- Reissues: PAR-18-410 Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
- 2 steps back: PAR-16-301 Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24)
Replaced by PAR-22-193.
Who won it before
37 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $26,860,367 in first-year total cost, median $653,807.
Most frequent study sections
- Clinical Trials Review Study Section[CLTR (MA)]12
- Clinical Trials Review Study Section[CLTR (JA)]9
- Clinical Trials Review Study Section[CLTR (OA)]5
- Special Emphasis Panel[ZHL1 CSR-H (F1)]2
- Special Emphasis Panel[ZHL1 CSR-H (F2)]2
Most frequent institutions
- DUKE UNIVERSITY5
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH4
- RESEARCH TRIANGLE INSTITUTE3
- GEORGE WASHINGTON UNIVERSITY2
- MASSACHUSETTS GENERAL HOSPITAL2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | 2/2 Circulatory Support in Pediatric Heart Failure Patients Using the Jarvik 2015 LVAD: A Pivotal Trial1U24HL163316-01A1 | MAGNAVITA, ASHLEYZAK, VICTOR | NEW ENGLAND RESEARCH INSTITUTES, INC., DE | $1,061,181 | ZHL1 |
| 2023 | 2/2 REPRIEVE Extension for Trial Completion1U24HL164284-01 | LU, MICHAEL TSE-YINRIBAUDO, HEATHER JANE | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,243,585 | ZHL1 |
| 2023 | 2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)1U24HL165029-01A1 | O'BRIEN, SEAN MVEMULAPALLI, SREEKANTH | DUKE UNIVERSITY, NC | $820,509 | ZHL1 |
| 2023 | 2/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease1U24HL166799-01 | EVANS, SCOTTRICE, MADELINE MURGUIASANDOVAL, GRECIO JAN | GEORGE WASHINGTON UNIVERSITY, DC | $789,172 | CLTR |
| 2023 | 2/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial1U24HL161359-01A1 | KING, WENDY CWISNIEWSKI, STEPHEN R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $445,858 | ZHL1 |
| 2022 | 2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation1U24HL165066-01 | HANLEY, DANIEL FTHOMPSON, RICHARDYENOKYAN, GAYANE | JOHNS HOPKINS UNIVERSITY, MD | $1,839,921 | CLTR |
| 2022 | 1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia1U24HL157560-01A1 | SHAW, BRONWEN | MEDICAL COLLEGE OF WISCONSIN, WI | $1,161,689 | ZHL1 |
| 2022 | 2/2 Trauma Resuscitation with Group O Whole Blood or Products (TROOP)1U24HL157310-01A1 | DESANTIS, STACIA | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $653,807 | CLTR |
| 2022 | 2/2 Pulmonary Embolism: Thrombus Removal with Catheter-Directed Therapy (PE-TRACT Trial) –DCC1U24HL155811-01A1 | TARPEY, THADDEUSTROXEL, ANDREA B | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $622,751 | CLTR |
| 2022 | 2/2 Percutaneous Intervention Versus Observational Trial of Arterial ductus management in Low-weight infants (PIVOTAL) Data Coordinating Center1U24HL161360-01 | KING, WENDY CWISNIEWSKI, STEPHEN R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $447,190 | ZHL1 |
| 2021 | 2/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy for Pediatric Pulmonary Arterial Hypertension-DCC1U24HL151457-01A1 | CHAKRABORTY, HRISHIKESHYENOKYAN, GAYANEZIMMERMAN, KANECIA OBIE | DUKE UNIVERSITY, NC | $935,417 | ZHL1 |
| 2021 | 2/2 Doxycycline for Emphysema in People Living with HIV: The DEPTH Trial1U24HL154946-01A1 | SPINO, CATHERINE A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $863,939 | CLTR |
| 2021 | 2/2 Pediatric Influence of Cooling duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)1U24HL159132-01 | YEATTS, SHARON DZIUBA | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $660,295 | CLTR |
| 2021 | 2/2 The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial1U24HL152304-01A1 | RATCLIFFE, SARAH J | UNIVERSITY OF VIRGINIA, VA | $544,353 | CLTR |
| 2021 | 2/2, Data Coordinating Center for the Long-term Effectiveness of the Anti-obesity medication Phentermine: the LEAP Trial1U24HL155802-01A1 | PAJEWSKI, NICHOLAS M. | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $449,621 | CLTR |
| 2021 | (2/2) Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH)1U24HL153846-01A1 | ABEBE, KALEAB Z | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $391,605 | CLTR |
| 2021 | 2/2 Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease (Tele-COPD)1U24HL155807-01A1 | ABAN, INMACULADA | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $360,392 | CLTR |
| 2020 | 2/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)1U24HL147018-01A1 · under PAR-18-410 | CASPER, THERON C | UNIVERSITY OF UTAH, UT | $906,728 | ZHL1 |
| 2020 | RACE-CARS DCC 2/21U24HL146938-01A1 · under PAR-18-410 | AL-KHALIDI, HUSSEINMARK, DANIEL B | DUKE UNIVERSITY, NC | $697,029 | CLTR |
| 2020 | 2/2: Sickle Cell Disease Treatment with Arginine Therapy (STArT) trial1U24HL148563-01A1 · under PAR-18-410 | CASPER, THERON C | UNIVERSITY OF UTAH, UT | $659,657 | ZHL1 |
| 2020 | 2/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis1U24HL147012-01A1 · under PAR-18-410 | CHEN, YING QINGHUANG, YING | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $508,756 | CLTR |
| 2020 | (2/2) Log2Lose: Incenting Weight Loss and Dietary Self-Monitoring in Real Time to Improve Weight Management1U24HL150227-01A1 | PENDERGAST, JANE FSHAW, RYAN JEFFREY | DUKE UNIVERSITY, NC | $414,768 | CLTR |
| 2020 | The Allogeneic Human Mesenchymal Stem Cell (MSCs) injection in Patients with Hypoplastic Left Heart Sydrome: A Phase IIb Clinical Trial (ELPIS)1U24HL148316-01A1 | DAVIS, BARRY R | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON, TX | $335,707 | CLTR |
| 2019 | 2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)1U24HL143217-01A1 · under PAR-18-410 | BROOKS, MARIA MORI | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $994,923 | ZHL1 |
| 2019 | 2/2 ICECAP: Influence of Cooling duration on Efficacy in Cardiac Arrest Patients1U24HL145272-01A1 · under PAR-18-410 | RAMAKRISHNAN, VISWANATHANYEATTS, SHARON DZIUBA | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $593,402 | CLTR |
| 2019 | Prospective tReatment EffiCacy in IPF uSlng genOtype for Nac Selection (PRECISIONS) trial and Molecular Endophenotyping in Idiopathic Pulmonary Fibrosis and Interstitial Lung Diseases study1U24HL145265-01A1 · under PAR-18-410 | FLAHERTY, KEVIN RSPINO, CATHERINE A | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $582,305 | CLTR |
| 2019 | 2/2 Pomalidomide for Bleeding in Patients with Hereditary Hemorrhagic Telangiectasia (HHT) Bleeding Data Coordinating Center1U24HL140090-01A1 · under PAR-18-410 | CATELLIER, DIANE J | RESEARCH TRIANGLE INSTITUTE, NC | $527,881 | CLTR |
| 2019 | 2/2: An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications: The PRIME-AIR Study.1U24HL140109-01A1 · under PAR-18-410 | PARKER, ROBERT A. | MASSACHUSETTS GENERAL HOSPITAL, MA | $488,203 | CLTR |
| 2019 | 2/1 Arrest Respiratory Failure due to Pneumonia (ARREST PNEUMONIA)1U24HL141727-01A1 · under PAR-18-410 | DESAI, MANISHA | STANFORD UNIVERSITY, CA | $377,990 | CLTR |
| 2019 | 2/2 PROmote weight loss in obese PAD patients to preVEnt mobility loss: The PROVE Trial--DCC1U24HL141732-01A1 · under PAR-18-410 | AMBROSIUS, WALTER T | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $221,385 | CLTR |
| 2018 | 2/2 A comparison of individualized vs. weight based protocols to treat vaso-occlusive episodes in Sickle Cell Disease (COMPARE VOE)1U24HL137907-01A1 · under PAR-16-301 | BARNHART, HUIMAN X | DUKE UNIVERSITY, NC | $1,333,276 | CLTR |
| 2018 | Transfusion of Prematurity Early School Age Follow-up (TOP 5) DCC1U24HL143216-01 · under PAR-16-301 | DAS, ABHIK | RESEARCH TRIANGLE INSTITUTE, NC | $1,298,791 | CLTR |
| 2018 | 2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women1U24HL140168-01 · under PAR-16-301 | CLIFTON, REBECCA GERSNOVIEZTHOM, ELIZABETH ANN | GEORGE WASHINGTON UNIVERSITY, DC | $1,091,697 | CLTR |
| 2018 | Impact of Low Flow Nocturnal Oxygen Therapy On Hospital Admissions and Mortality in Patients with Heart Failure and Central Sleep Apnea - DCC1U24HL140412-01 · under PAR-16-301 | REDLINE, SUSAN S.WANG, RUI | BRIGHAM AND WOMEN'S HOSPITAL, MA | $896,611 | CLTR |
| 2018 | 2/2 PROSpect: Prone and Oscillation Pediatric Clinical Trial (DCC)1U24HL141723-01 · under PAR-16-301 | WYPIJ, DAVID | BOSTON CHILDREN'S HOSPITAL, MA | $812,214 | ZHL1 |
| 2017 | 2/2 Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRiD Outcomes Study): Data Coordinating Center1U24HL137729-01 · under PAR-16-301 | DAS, ABHIK | RESEARCH TRIANGLE INSTITUTE, NC | $487,278 | CLTR |
| 2017 | 2/2 Catheter-Directed Therapy for Chronic DVT (C-TRACT Trial)-DCC1U24HL137835-01 · under PAR-16-301 | KEARON, CLIVE | MCMASTER UNIVERSITY, ON | $340,481 | CLTR |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.